23rd Annual Biotech in Europe Forum

FOR GLOBAL PARTNERING & INVESTMENT

20th - 21st of September 2023|MÖVENPICK HOTEL | BASEL | SWITZERLAND

Attendees:

+ND Capital

3B Future Health Ventures

4BIO Capital

4NEURON

AAA Family Office

AATec Medical GmbH

Accequa AB

Accure Therapeutics S.L.

Achilles Therapeutics plc/ Avantium NV/ LabGenius Ltd.

ACM Biosciences AG

AdBio Partners

AdimaBio Ventures

Adiso Therapeutics

Adoram Therapeutics SA

Adrenomed AG

AESARA Europe Ltd.

AFK & Partners Asset Management LLC

Agile Capital Markets

AiCuris Anti-infective Cures AG

Akribion Genomics AG

Alentis Therapeutics AG

Aliath Bioventures

Allogenica

Alloy Therapeutics

Alpha Blue Ocean

ALSA Ventures

AM-Pharma B.V.

AmacaThera Inc.

Amarna Therapeutics B.V.

AMR Action Fund GP GmbH

Amyl Therapeutics

Anaveon AG

Andera Partners

Angelini Ventures S.p.A.

Ankrin Therapeutics ApS

Apollo Health Ventures

Aqua Partners LLC

ARENSIA Exploratory Medicine GmbH

ARMGO Pharma

ARTO AG

Asklepios Advisors

Astellas Pharma Europe Ltd.

AstraZeneca

Atamyo Therapeutics SAS

AtG Therapeutics

ATGN Consulting

Athos Group

Atlas Capital Markets

Atriva Therapeutics GmbH

Aurealis Therapeutics AG

AurorA Science Srl

AVANTECA Partners AG

Awen GmbH

AXA Investment Managers

Axoltis Pharma

Azafaros B.V.

B'IMPRESS

BaseLaunch

Bayer AG

BeiGene Ltd.

Bergmann zur Hausen & Cie. GmbH

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioGeneration Ventures

BioMedPartners AG

BiomedVC AG

Biomunex Pharmaceuticals

BIOPHTA

Bioqube Ventures

BioReperia AB

BIOSTART Consulting GmbH

Biotx.ai

BioValley Basel

BioValley Basel & Suterscience

Bioxodes SA

BioZen Limited

BiPER Therapeutics

Bird & Bird LLP

Bloomberg Intelligence

Boehler Life Science Advice

Bootstrap Europe

Borea Therapeutics S.r.l

Boston Consulting Group

Bpifrance

Bradley Woods & Co. Ltd.

Brenus Pharma

Breslin AG & LSFA

Brightlands Venture Partners

Bristol-Myers Squibb SA

Brookline Capital Markets

BROTHERS & Partners Europe

Bukwang Pharmaceutical Co.

Business Angels Switzerland

CaleeTech

Calypso Biotech BV

Cambridge Allergy Ltd

Canton of Basel-Stadt

Cardior Pharmaceuticals GmbH

CasInvent Pharma

CaSRevolution S.r.l.

Catalytic Impact Foundation

Catenion GmbH

CBT Advisors

CDR-Life AG

Cellestia Biotech AG

CellProthera SAS

CILcare

Cimeio Therapeutics AG

CIS Biopharma AG

Claris Ventures

Cogentia Healthcare Consulting Ltd.

Cohesion Bureau

Convergence Partners AG

CorFlux

Corianthian Financial Investments

Coulter Partners

Crosswave Management

CTI Life Sciences Fund

Cukierman & Co. Life Sciences

Cullgen Inc.

Cutanos GmbH

Darmiyan

Debiopharm International S.A.

Delin Ventures Ltd.

Delta 4 GmbH

Diaceutics PLC

Diamante Società Benefit Srl

Digital Networks Plc. S.r.l.

docdok.health Ltd.

Domain Therapeutics SA

Dynamic Biosensors GmbH

Earlybird Venture Capital

Edison Group

Egle Therapeutics SAS

EIT Health e.V.

eleva GmbH

Eli Lilly and Company

Eligo Bioscience

Eliraz Ventures

Engimmune Therapeutics AG

Epicelya Therapeutics i.Gr.

EQT Life Sciences

ESC Advisors

European Investment Bank

European Investment Fund

Evernow Publishing Ltd

Eversheds Sutherland (US) LLP

Feel Therapeutics

Ferghana Partners

FimmCyte AG

Forbion

Forty51 Ventures

Forty51 Ventures AG

Fraser Partners

Fund+

GAOMA Therapeutics

Generation Fund Life Sciences Fund I

GeNeuro SA

GeNInG Bioscience GmbH

Genius Search GmbH & Co. KG

GenSearch Switzerland

German Accelerator Life Sciences

GIBF

Gilde Healthcare Partners

Gimv

GliaPharm SA

Globescape Capital Inc

GLSV GmbH iL

GSK

Guest

H Tree Capital

H. Lundbeck A/S

H.C. Wainwright & Co.

Hadean Ventures

HBM Partners AG

HCH of Independent

Health Innovation Capital

HealthCap

Healthspan Capital LP

Herantis Pharma Plc

Hitachi Ventures GmbH

HitchinRock Advisors Limited

i&i Biotech Fund

IAG Italian Angels for Growth

IAMA Therapeutics S.r.l.

ICF Consult Switzerland

Ikxinta GmbH

Ilonov

IMGM Laboratories GmbH

Immodulon Therapeutics Ltd

Impact Omics BV

In Vivo

InCephalo Therapeutics

Indaco Bio Fund

Indaco Venture Partners SGR S.p.A.

Independent - CB

Independent - KF

Independent - SG

Inkef

InnoGrant Advisors KLG

iNpart AG

Insilico Medicine

Instinctif Partners Ltd.

Intract Pharma Ltd.

Inveready Asset Management S.G.E.I.C.

Invest Hong Kong

INVITRIS

iOnctura SA

IPF Partners

iPSirius

ISA Pharmaceuticals B.V.

JFG Life Sciences Stiftung der Universität Basel

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation | Janssen Business Development

Johnson & Johnson Innovation LLC

JPMorgan Chase & Co.

Karista

KBI Biopharma

Kicker Ventures

KIZOO Technology Capital GmbH

Kurma Partners

L.E.K. Consulting LLP

Lactocore Inc.

Ladenburg Thalmann & Co. Inc.

LanceBio Ventures

Landmark Family Office/Landmark Angels

LaRive Bio AG

Latham & Watkins LLP

leon-nanodrugs GmbH

LifeCare Partners GmbH

LIfT BioSciences Ltd.

Lightstone Ventures

LMU Munich

Lonza AG

Lumira Ventures

Lynx Financial

Lyonbiopôle

M Ventures

Medical Valley EMN e.V.

Medicover AB

Medicxi

MEDiSTRAVA Consulting

Merck KGaA

Mergermarket

Merieux Equity Partners

MetrioPharm AG

Mid Atlantic Bio Angels

Mnemo Therapeutics

Moderna

Modiblast Pharma GmbH

Modra Pharmaceuticals B.V.

Momentum Biotech LLC

MSQ Ventures

Mysthera Therapeutics AG

Nawrath BrightSpots LLC

Neurimmune AG

New Harbor Venture Partners

New Science Fund

Nextech Invest Ltd.

NFL Biosciences

NovaQuest Capital Management

Novartis AG

Novartis Venture Fund

Novo Holdings A/S

NRW.Venture

NxR Biotechnologies GmbH

Oberland Capital

OCT Clinical GmbH

Octopus Ventures

ODDO BHF

Odimma Therapeutics

Omega Fund Management (US)

On/Off Therapeutics SAS

Oncode Bridge Fund .Bv

OrbiMed Advisors LLC

Oryzon Genomics

OSE Immunotherapeutics

Osivax

Osta Therapeutics

Otten Life Sciences Consulting Sàrl

Pacertool AS

PAGE Therapeutics AG

Panakès Partners SGR SpA

Partner International Inc.

Paul Larue Business Development Consulting

PDC*line Pharma SA

PEP-Therapy

PerioTrap Pharmaceuticals GmbH

PFR Ventures

PharmaVentures Ltd.

Pictet & Cie SA

PRAMOMOLECULAR GmbH

Preci LLC

Prevail Partners LLC

Prokarium Ltd.

ProVascTec Ltd

Pureos Bioventures

Quadrille Capital

Quan Capital

RBV Capital

Reconnect Labs AG

Resistell AG

Resuscitec GmbH

Roivant Sciences GmbH

Rosetta Capital Ltd.

Roy Consulting

RV Invest GmbH

RYSE Asset Management

Salvina Therapeutics AG

Secarna Pharmaceuticals GmbH & Co. KG

Second Thought

Seekyo

Seroba Life Sciences

Seventure Partners

SiSaf Ltd.

Sofinnova Partners

Sound Bioventures Management AB

SparingVision

SPRIM Global Investments

Staatz Business Development & Strategy

StemSight Oy

sterna biologicals GmbH

Stifel

STIMUNITY SAS

STipe Therapeutics

Strategic Transactions Advisory AG

Stratos Bio

Strike Pharma AB

Summit Partners Limited

Supernova Invest

Swarm Oncology Ltd.

Swiss Biotech Association

Syncona Investment Management Ltd.

Syndivia

T-CURX GmbH

Taiho Ventures

Tandem Ventures Srl

TargImmune Therapeutics AG

Technologiepark Heidelberg GmbH

Teitur Trophics

The BioIndustry Association

The FreeMind Group

The Fulford Group Ltd.

TheraOnco

TheraVenture GmbH

Thermosome GmbH

tiakis Biotech AG

Tiger Gene

TOLREMO Therapeutics AG

Topas Therapeutics GmbH

TruVenturo GmbH

Turos Capital AG

TVM Capital Life Science

TVM Life Science Management GmbH

UCB Ventures

University of Zurich

V-Bio Ventures BV

Vaccentis AG

Valor Management S.A.

VarmX B.V.

Venture Valuation AG

Vesalius Biocapital Partners Sàrl

VI Partners AG

ViGeneron / BGV

Viopas Venture Consulting

VirdisGroup

Virtual Nomad LLC

VMS Group

Vogel BioC

VU Venture Partners

VUS Diagnostics

WBB Securities

Wellington Partners

WG Partners LLP

WMT AG

Wyss Center for Bio and Neuroengineering

X-Chem

XGen Venture SGR S.p.A.

XNK Therapeutics AB

Xontogeny

XOventure GmbH

Ymmunobio AG

Ysios Capital Partners S.G.E.I.C.

Last updated: September 25, 2023